ALID - Allied Corp Strengthens Leadership Team to Drive Execution and Global Expansion
(TheNewswire)
Kelowna, BC, Canada – February 25, 2025 – TheNewswire - Allied Corp . ("Allied" or the “Company”) is pleased toannounce key leadership appointments as the Company moves to anexciting phase of growth with a focus on execution of establishedcommercial contracts, within the expanding global medical cannabismarket. The newly appointed management team and directors bring deepknowledge in pharmaceutical compliance, a strong expertise inoperations and execution, and a track record of global marketexpansion within regulated industries.
KEY APPOINTMENTS :
Jim Smeeding – Chairman of theBoard
A long-standing Board member, Jim is a Healthcare andPharmacy executive with 45+ years experience in hospital pharmacy,managed care services and clinical services design. An entrepreneurhimself, he has successfully built and led several pharmaceuticalcompanies from funding to sale and advises major pharma and medicaldevice firms. A founder of the Center for Pharmacoeconomic Studies atthe University of Texas College Of Pharmacy, Jim also served as anExecutive Director of the National Association of Specialty Pharmacy(NASP).
Simon Langelier – Director
A seasoned multinational executive and board member,Simon has 40+ years experience in cannabis, tobacco and consumergoods. 30+ years of leadership experience at Philip MorrisInternational (PMI), where he led market expansion, M&A andoperational restructuring across Europe, Asia, the Middle East andAfrica. Among other positions at PMI, he was Managing Director forColombia, President EEMA and President Eastern Asia. Simon also servedon the Board of Imperial Brands. His expertise in strategy andexpansion across global markets in highly regulated industries will beinvaluable for the execution of Allied’s next phase ofgrowth.
Abdul Musoke – Director
Abdul is a corporate strategist with expertise inmarket expansion, regulatory oversight and financial structuring.As Chief Strategy Officer at Afri Digital Media Corp, heleads strategic acquisitions and regulatory compliance across Africa.He also serves as Director at Albertine Nuts Uganda Ltd, overseeingfinance and partnerships for a 500-acre macadamia orchard. Abdul’sexperience in regulatory economics, M&A, and multinationalnegotiations will be instrumental in guiding Allied’s globalexpansion and operational scale-up.
Michael Moses – Chief ExecutiveOfficer
Michael has played a pivotal role in establishingAllied’s long-term strategy and commercializing its medical cannabisproducts, laying a strong foundation for the business’ next phase ofgrowth. As Chief Business Development Officer, he launched theCompany’s commercial arm, rolled out the salesstrategy, built the client pipeline and secured multi-yearpartnerships in key medical markets. He also led Allied’soperational restructuring, including workflow optimisation, governanceand building a scalable structure to align production, sales andcompliance. Michael, an experienced entrepreneur with an EngineeringMasters and a background in consulting and investment management,previously founded and scaled an award-winning digital marketing B2Bbusiness.
With a seasoned leadership team in place, Allied iswell-positioned to execute on its commercial strategy and existingcontracts, expand into new markets and strengthen its role as acost-efficient supplier of pharmaceutical-grade cannabis globally. Thecompany is committed to delivering long-term shareholder value and todrive its next phase of growth.
About Allied Corp. – CLICK HERE
AlliedCorp. is a Canadiancannabis supplier with its production center in Colombia. Byleveraging Canadiancannabis cultivation expertise and Colombian price advantages, Allied offers consistentsupply of premium cannabis product at scale and at attractive prices,meeting international high-quality standards.
Investor Relations:
Disclaimer andForward-Looking Statements:
No regulatory authority assumesresponsibility for the accuracy or adequacy of thisrelease.
This press release includes certainstatements that may be deemed "forward-looking statements"under U.S. and Canadian securities laws. Forward-looking statementsrelate to Allied Corp.’s anticipated developments, strategicobjectives, performance, and market opportunities. These include, butare not limited to, statements regarding Allied’s growth inColombia, Kelowna, Nevada, and other key locations; intellectualproperty filings; joint development and manufacturing initiatives; andplanned product introductions.
Forward-looking statements can often beidentified by terms such as "anticipates,""believes," "expects," "intends,""plans," "will," "may," and similarexpressions. These statements are based on current assumptions,projections, and management’s experience, but are subject to knownand unknown risks and uncertainties that may cause actual results todiffer materially. Notable risks include, but are not limited to,regulatory risks associated with the cannabis industry and marketchanges ; risks related to competition within the cannabis and medicalindustries; risks related to potential operational and logisticalchallenges; risks related to market demand; risks related to economicconditions impacting growth and profitability; risks related topotential delays or adverse changes in project locations or expansionplans; as well as other risks.
Though Allied endeavors to identifyimportant factors that may impact actual outcomes, other unknownfactors may also cause results to vary. The forward-looking statementscontained in this news release are made as of the date of this newsrelease. Except as required by law, the Company disclaims anyintention and assumes no obligation to update or revise anyforward-looking statements, whether as a result of new information,future events or otherwise. Additionally, the Company undertakes noobligation to comment on the expectations of, or statements made, bythird parties in respect of the matters discussed above.
Copyright (c) 2025 TheNewswire - All rights reserved.